On March 31, 2017 Pfizer Canada Inc., the Canadian distributor of EpiPen® (epinephrine) Auto-Injector, announced a voluntary recall, in consultation with Health Canada, of one lot of EpiPen 0.3 mg (epinephrine) and one lot of EpiPen Jr 0.15 mg (epinephrine) Auto-Injectors distributed in Canada. The recall is being conducted as a result of the receipt of two previously disclosed reports outside of Canada of failure to activate the device due to a potential defect in a supplier component. The potential defect could make the device difficult to activate in an emergency (failure to activate or increased force needed to activate) and have significant health consequences for a patient experiencing a life-threatening allergic reaction (anaphylaxis). Patients should keep their existing product until their replacement product can be secured.
Parents should contact to the prescribing pharmacy immediately, to determine if the EpiPen® their student uses falls within the recall parameters.
Please use the following link for more information: http://www.pfizer.ca/node/7651